Diverse by nature – experts by design
Cell & Gene therapies spread across a wide range of modalities. As the leading CDMO in this space, we are constantly investing and developing our extensive experience across this broad spectrum, including emerging new modalities, to provide you with the expertise you need for your therapy.
We provide a wide of range of services to suit your development, clinical and commercial manufacturing stage. Whether you wish to work on clinical, commercial manufacturing or on bringing your therapy from concept to patients, we can help you achieve your goals.
Customized Cell & Gene technologies for cGMP manufacturing
While we pride ourselves in being fully technology agnostic for our customers, our proprietary cell & gene therapy manufacturing technologies are always available to our customers, at any stage of development.
Establishing the Standards of Operational Excellence to Manufacture Commercial Cell Therapies
bluebird bio and Lonza reflect on their 10-year journey commercializing two gene therapies
Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon® Platform
Automated T Cell Therapy Manufacturing in the Cocoon® Platform
Improvement of Precision in Recombinant Adeno-Associated Virus Infectious Titer Assay with Droplet...
Bioanalytical Challenges in the Development and Validation of Bioassays used in Cell Therapy
Improved and Rebalanced Helper and RepCap Plasmids to Ramp up your AAV Productivity
Lonza’s Rapid PyroCell® Monocyte Activation Test Systems Make Rabbit-Free Pyrogen Testing Faster,...
Lonza Upgrades MODA-ES® Module for Enhanced Electronic Batch Record Execution
Lonza and Vertex Celebrate Groundbreaking of Cell Therapy Manufacturing Facility in Portsmouth (US)
Lonza Launches Nebula® Absorbance Reader for Streamlined Endotoxin and Pyrogen Testing
Lonza Launches TheraPRO® CHO Media System to Improve Productivity and Quality in Therapeutic Protein...
Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies
Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium to Accelerate Cell Therapy Development
Lonza Expands Global Process Development Team and Laboratory Spaces for Cell and Gene Development
Lonza and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bioreactors with...
More Sensitive Non-endotoxin Pyrogen Detection Now Possible with Lonza’s New PyroCell Monocyte...
Lonza Expands the Functionality of Cocoon Platform by Implementing Magnetic Cell Selection
Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model...
Lonza Obtains Order Preventing Infringement of Its Patents Covering the Cocoon® Platform
By joining Lonza, you will get to work with some of the world’s top experts in the space, while developing advanced therapies with a potentially life-saving outcome.
Behnam Ahmadian Baghbaderani
Global Head of Process Development